📣 VC round data is live. Check it out!

Alcidion Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for Alcidion Group and similar public comparables like Oneview Healthcare, Fonet, Revium Recovery, Findex and more.

Alcidion Group Overview

About Alcidion Group

Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.


Founded

2010

HQ

Australia

Employees

136

Financials (LTM)

Revenue: $33M
EBITDA: $4M

EV

$96M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Alcidion Group Financials

Alcidion Group reported last 12-month revenue of $33M and EBITDA of $4M.

In the same LTM period, Alcidion Group generated $26M in gross profit, $4M in EBITDA, and $878K in net income.

Revenue (LTM)


Alcidion Group P&L

In the most recent fiscal year, Alcidion Group reported revenue of $27M and EBITDA of $4M.

Alcidion Group is profitable as of last fiscal year, with gross margin of 74%, EBITDA margin of 13%, and net margin of 4%.

See analyst estimates for Alcidion Group
LTMLast FY202320242025202620272028
Revenue$33M$27M$28M$25M$28M
Gross Profit$26M$20M$24M$21M$23M
Gross Margin79%74%86%86%81%
EBITDA$4M$4M($2M)$178K$4M
EBITDA Margin13%13%(8%)1%14%
EBIT Margin3%1%(17%)(26%)(10%)
Net Profit$878K$1M($4M)($2M)$1M
Net Margin3%4%(16%)(10%)4%

Financial data powered by Morningstar, Inc.

Alcidion Group Stock Performance

Alcidion Group has current market cap of $105M, and enterprise value of $96M.

Market Cap Evolution


Alcidion Group's stock price is $0.08.

Alcidion Group share price increased by 7.4% in the last 30 days, and by 28.4% in the last year.

See more trading valuation data for Alcidion Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$96M$105M-0.1%7.4%4.2%28.4%$0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Alcidion Group Valuation Multiples

Alcidion Group trades at 2.9x EV/Revenue multiple, and 22.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Alcidion Group

EV / Revenue (LTM)


Alcidion Group Financial Valuation Multiples

As of May 24, 2026, Alcidion Group has market cap of $105M and EV of $96M.

Alcidion Group has a P/E ratio of 120.1x.

LTMLast FY202320242025202620272028
EV/Revenue2.9x3.6x3.5x3.9x3.4x
EV/EBITDA22.0x26.9x(45.4x)n/m23.8x
EV/EBIT108.0xn/m(20.1x)(15.1x)(34.6x)
EV/Gross Profit3.7x4.9x4.0x4.5x4.2x
P/E120.1x89.3x(24.6x)(43.7x)103.6x
EV/FCF26.6x23.9x(36.0x)(174.3x)25.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Alcidion Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Alcidion Group Margins & Growth Rates

Alcidion Group grew revenue by 26% and EBITDA by 26% in the last fiscal year.

In the most recent fiscal year, Alcidion Group reported gross margin of 74%, EBITDA margin of 13%, and net margin of 4%.

See estimated margins and future growth rates for Alcidion Group

Alcidion Group Margins

Last FY202420252026202720282029
Gross Margin74%86%81%81%
EBITDA Margin13%1%14%15%
EBIT Margin1%(26%)(10%)5%
Net Margin4%(10%)4%4%
FCF Margin15%(2%)13%12%

Alcidion Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth26%(10%)14%22%
Gross Profit Growth34%(11%)8%22%
EBITDA Growth26%(108%)2166%31%
EBIT Growth302%33%(56%)(157%)
Net Profit Growth(28%)(44%)(142%)33%
FCF Growth(10%)(79%)(793%)11%

Data powered by FactSet, Inc. and Morningstar, Inc.

Alcidion Group Operational KPIs

Alcidion Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Alcidion Group's Rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Alcidion Group's Rule of X is 71% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Alcidion Group
LTMLast FY202320242025202620272028
Rule of 4021%38%———
Bessemer Rule of X34%71%———
Revenue per Employee—$0.2M———
Opex per Employee—$0.2M———
S&M Expenses to Revenue—2%2%2%2%
G&A Expenses to Revenue—71%73%79%67%
Opex to Revenue—98%103%111%92%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Alcidion Group Competitors

Alcidion Group competitors include Oneview Healthcare, Fonet, Revium Recovery, Findex, CareCloud, Apiam Animal Health, OptimizeRx, Definitive Healthcare, JLK and Nano X Imaging.

Most Alcidion Group public comparables operate across Healthcare Software, EHR & Practice Management, B2B SaaS, Vertical SaaS and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Oneview Healthcare7.2x6.7x(9.3x)(11.2x)
Fonet5.7x—11.5x—
Revium Recovery————
Findex2.7x2.7x7.6x7.7x
CareCloud0.8x0.8x3.5x3.5x
Apiam Animal Health—1.4x—13.7x
OptimizeRx0.9x0.9x4.0x4.1x
Definitive Healthcare0.3x0.3x1.1x1.2x

This data is available for Pro users. Sign up to see all Alcidion Group competitors and their valuation data.

Start Free Trial

Alcidion Group Funding History

Before going public, Alcidion Group raised $2M in total equity funding, across 1 round.


Alcidion Group Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Mar-15Seed—$2M——

Alcidion Group M&A Activity

Alcidion Group has acquired 6 companies to date.

Last acquisition by Alcidion Group was on May 17th 2026. Alcidion Group acquired Kyra Flow (certain assets) for $3M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Alcidion Group

Kyra Flow (certain assets)
Silverlink Software
Extramed Limited
MKM Health
Description
Kyra Flow (certain assets) is a digital health software suite designed to address operational challenges in public and private hospital environments.
Silverlink Software is a U.K. provider of patient administration systems deployed in 13 NHS acute trusts across 45 hospitals. The PCS platform handles admissions, discharges, and reporting compliant with national guidelines. It supports multidisciplinary data sharing for emergency and elective care. With 20 years of NHS experience, Silverlink updates modules for theater scheduling and bed management.
Extramed Limited is a UK software developer delivering real-time patient flow analytics for NHS trusts. Headquartered in Wokingham, its dashboard tracks bed occupancy, discharge readiness, and ambulance handovers across 20+ hospitals. Deployed in trusts like Frimley Health, it reduces delays by integrating with Cerner Millennium EPR.
MKM Health is a Sydney-headquartered IT consultancy for the Australian healthcare sector, implementing hospital information systems, electronic health records, and informatics platforms. The firm integrates vendor solutions from Cerner and Epic, providing strategic advisory on digital health trends, systems interoperability, and data analytics for public hospitals and private clinics nationwide.
HQ Country—United KingdomUnited KingdomAustralia
HQ City
—
Newcastle
Wakefield
Sydney
Deal Date17 May 20267 Dec 202115 Apr 202124 Apr 2018
Valuation$3M$36M$6M$8M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Alcidion Group acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Alcidion Group

When was Alcidion Group founded?Alcidion Group was founded in 2010.
Where is Alcidion Group headquartered?Alcidion Group is headquartered in Australia.
How many employees does Alcidion Group have?As of today, Alcidion Group has over 136 employees.
Is Alcidion Group publicly listed?Yes, Alcidion Group is a public company listed on Australian Securities Exchange.
What is the stock symbol of Alcidion Group?Alcidion Group trades under ALC ticker.
When did Alcidion Group go public?Alcidion Group went public in 2011.
Who are competitors of Alcidion Group?Alcidion Group main competitors include Oneview Healthcare, Fonet, Revium Recovery, Findex, CareCloud, Apiam Animal Health, OptimizeRx, Definitive Healthcare, JLK, Nano X Imaging.
What is the current market cap of Alcidion Group?Alcidion Group's current market cap is $105M.
What is the current revenue of Alcidion Group?Alcidion Group's last 12 months revenue is $33M.
What is the current revenue growth of Alcidion Group?Alcidion Group revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Alcidion Group?Current revenue multiple of Alcidion Group is 2.9x.
Is Alcidion Group profitable?Yes, Alcidion Group is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Alcidion Group?Alcidion Group's last 12 months EBITDA is $4M.
What is Alcidion Group's EBITDA margin?Alcidion Group's last 12 months EBITDA margin is 13%.
What is the current EV/EBITDA multiple of Alcidion Group?Current EBITDA multiple of Alcidion Group is 22.0x.
What is the current FCF of Alcidion Group?Alcidion Group's last 12 months FCF is $4M.
What is Alcidion Group's FCF margin?Alcidion Group's last 12 months FCF margin is 11%.
What is the current EV/FCF multiple of Alcidion Group?Current FCF multiple of Alcidion Group is 26.6x.
How many companies Alcidion Group has acquired to date?As of May 2026, Alcidion Group has acquired 6 companies.
What was the largest acquisition by Alcidion Group?$36M acquisition of Silverlink Software on 7th December 2021 was the largest M&A Alcidion Group has done to date.
What companies Alcidion Group acquired?Alcidion Group acquired Silverlink Software, MKM Health, Extramed Limited, Kyra Flow (certain assets), Oncall Systems Ltd., and Patientrack.
In how many companies Alcidion Group has invested to date?Alcidion Group hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Alcidion Group

Lists including Alcidion Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial